|
1
|
Wheeler AP and Bernard GR: Acute lung
injury and the acute respiratory distress syndrome: A clinical
review. Lancet. 369:1553–1564. 2007.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Fan E, Brodie D and Slutsky AS: Acute
respiratory distress syndrome: Advances in diagnosis and treatment.
JAMA. 319:698–710. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
He YQ, Zhou CC, Yu LY, Wang L, Deng JL,
Tao YL, Zhang F and Chen WS: Natural product derived phytochemicals
in managing acute lung injury by multiple mechanisms. Pharmacol
Res. 163(105224)2021.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Matthay MA and Zimmerman GA: Acute lung
injury and the acute respiratory distress syndrome: Four decades of
inquiry into pathogenesis and rational management. Am J Respir Cell
Mol Biol. 33:319–327. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sahetya SK, Goligher EC and Brower RG:
Fifty years of research in ARDS. setting positive end-expiratory
pressure in acute respiratory distress syndrome. Am J Respir Crit
Care Med. 195:1429–1438. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Deng JC and Standiford TJ: Growth factors
and cytokines in acute lung injury. Compr Physiol. 1:81–104.
2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Grommes J, Morgelin M and Soehnlein O:
Pioglitazone attenuates endotoxin-induced acute lung injury by
reducing neutrophil recruitment. Eur Respir J. 40:416–423.
2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Johnston CJ, Finkelstein JN, Gelein R and
Oberdorster G: Pulmonary cytokine and chemokine mRNA levels after
inhalation of lipopolysaccharide in C57BL/6 mice. Toxicol Sci.
46:300–307. 1998.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Martins HC and Schratt G:
MicroRNA-dependent control of neuroplasticity in affective
disorders. Transl Psychiatry. 11(263)2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Zhao W, Sun Q, Yu Z, Mao S, Jin Y, Li J,
Jiang Z, Zhang Y, Chen M, Chen P, et al: MiR-320a-3p/ELF3 axis
regulates cell metastasis and invasion in non-small cell lung
cancer via PI3K/Akt pathway. Gene. 670:31–37. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ferruelo A, Penuelas O and Lorente JA:
MicroRNAs as biomarkers of acute lung injury. Ann Transl Med.
6(34)2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Nusslein-Volhard C and Wieschaus E:
Mutations affecting segment number and polarity in
Drosophila. Nature. 287:795–801. 1980.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Ciesielska A, Matyjek M and Kwiatkowska K:
TLR4 and CD14 trafficking and its influence on LPS-induced
pro-inflammatory signaling. Cell Mol Life Sci. 78:1233–1261.
2021.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Plociennikowska A, Hromada-Judycka A,
Borzecka K and Kwiatkowska K: Co-operation of TLR4 and raft
proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life
Sci. 72:557–581. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Sukkar MB, Xie S, Khorasani NM, Kon OM,
Stanbridge R, Issa R and Chung KF: Toll-like receptor 2, 3, and 4
expression and function in human airway smooth muscle. J Allergy
Clin Immunol. 118:641–648. 2006.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Baumgarten G, Knuefermann P, Wrigge H,
Putensen C, Stapel H, Fink K, Meyer R, Hoeft A and Grohé C: Role of
Toll-like receptor 4 for the pathogenesis of acute lung injury in
Gram-negative sepsis. Eur J Anaesthesiol. 23:1041–1048.
2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Jiang K, Guo S, Zhang T, Yang Y, Zhao G,
Shaukat A, Wu H and Deng G: Downregulation of TLR4 by miR-181a
provides negative feedback regulation to lipopolysaccharide-induced
inflammation. Front Pharmacol. 9(142)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang J, Chen Y, Jiang K, Zhao G, Guo S,
Liu J, Yang Y and Deng G: MicroRNA-182 supplies negative feedback
regulation to ameliorate lipopolysaccharide-induced ALI in mice by
targeting TLR4. J Cell Physiol. 235:5925–5937. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Acute Respiratory Distress Syndrome
Network. Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT
and Wheeler A: Ventilation with lower tidal volumes as compared
with traditional tidal volumes for acute lung injury and the acute
respiratory distress syndrome. N Engl J Med. 342:1301–1308.
2000.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Guillamat-Prats R, Puig F,
Camprubi-Rimblas M, Herrero R, Serrano-Mollar A, Gómez MN, Tijero
J, Matthay MA, Blanch L and Artigas A: Intratracheal instillation
of alveolar type II cells enhances recovery from acute lung injury
in rats. J Heart Lung Transplant. 37:782–791. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Yang Y, Yang F, Yu X, Wang B, Yang Y and
Zhou X, Cheng R, Xia S and Zhou X: MiR-16 inhibits NLRP3
inflammasome activation by directly targeting TLR4 in acute lung
injury. Biomed Pharmacother. 112(108664)2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
McCarter SD, Mei SH, Lai PF, Zhang QW,
Parker CH, Suen RS, Hood RD, Zhao YD, Deng Y, Han RN, et al:
Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J
Respir Crit Care Med. 175:1014–1026. 2007.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wu CT, Huang Y, Pei ZY, Xi X and Zhu GF:
MicroRNA-326 aggravates acute lung injury in septic shock by
mediating the NF-kappaB signaling pathway. Int J Biochem Cell Biol.
101:1–11. 2018.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Yang J, Chen Y, Jiang K, Yang Y, Zhao G,
Guo S and Deng G: MicroRNA-106a provides negative feedback
regulation in lipopolysaccharide-induced inflammation by targeting
TLR4. Int J Biol Sci. 15:2308–2319. 2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chungen Y, Dongfang Z and Guoyuan X:
MicroRNA-146a protects against ischemia/reperfusion liver injury
through inhibition of toll-like receptor 4 signaling pathway in
rats. Transplant Proc. 52:1007–1013. 2020.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Butt Y, Kurdowska A and Allen TC: Acute
lung injury: A clinical and molecular review. Arch Pathol Lab Med.
140:345–350. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Xu B, Chen SS, Liu MZ, Gan CX, Li JQ and
Guo GH: Stem cell derived exosomes-based therapy for acute lung
injury and acute respiratory distress syndrome: A novel therapeutic
strategy. Life Sci. 254(117766)2020.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Matthay MA, Ware LB and Zimmerman GA: The
acute respiratory distress syndrome. J Clin Invest. 122:2731–2740.
2012.PubMed/NCBI View
Article : Google Scholar
|
|
30
|
Gao XQ, Li YF and Jiang ZL: Impact of
statins on ALI/ARDS: A meta-analysis. Pulm Pharmacol Ther.
39:85–91. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shah D, Das P, Acharya S, Agarwal B,
Christensen DJ, Robertson SM and Bhandari V: Small immunomodulatory
molecules as potential therapeutics in experimental murine models
of acute lung injury (ALI)/acute respiratory distress syndrome
(ARDS). Int J Mol Sci. 22(2573)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Imai Y, Kuba K, Neely GG,
Yaghubian-Malhami R, Perkmann T, van Loo G, Ermolaeva M, Veldhuizen
R, Leung YH, Wang H, et al: Identification of oxidative stress and
Toll-like receptor 4 signaling as a key pathway of acute lung
injury. Cell. 133:235–249. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Sun J, Zhuang Z, Zheng J, Li K, Wong RL,
Liu D, Huang J, He J, Zhu A, Zhao J, et al: Generation of a Broadly
useful model for COVID-19 pathogenesis, vaccination, and treatment.
Cell. 182:734–743.e5. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Pascarella G, Strumia A, Piliego C, Bruno
F, Del Buono R, Costa F, Scarlata S and Agrò FE: COVID-19 diagnosis
and management: A comprehensive review. J Intern Med. 288:192–206.
2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Zhou M, Zhang Y, Tang R, Liu H, Du M, Gao
Z, Ji Z and Fang H: HMGB1/TLR4 signaling affects regulatory T cells
in acute lung injury. J Inflamm Res. 14:1551–1561. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang W, Zhuang N, Liu X, He L, He Y,
Mahinthichaichan P, Zhang H, Kang Y, Lu Y, Wu Q, et al: The
metabolic regulator Lamtor5 suppresses inflammatory signaling via
regulating mTOR-mediated TLR4 degradation. Cell Mol Immunol.
17:1063–1076. 2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Knoops B, Becker S, Poncin MA, Glibert J,
Derclaye S, Clippe A and Alsteens D: Specific interactions measured
by AFM on living cells between peroxiredoxin-5 and TLR4: Relevance
for mechanisms of innate immunity. Cell Chem Biol. 25:550–559.e3.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Martin TR and Wurfel MM: A TRIFfic
perspective on acute lung injury. Cell. 133:208–210.
2008.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Feng L, Yang N, Li C, Tian G, Wang J, Dong
ZB, Jia XB and Di LQ: Pudilan xiaoyan oral liquid alleviates
LPS-induced respiratory injury through decreasing nitroxidative
stress and blocking TLR4 activation along with NF-ΚB
phosphorylation in mice. J Ethnopharmacol. 214:292–300.
2018.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wang C, Li Q and Li T: Dioscin alleviates
lipopolysaccharide-induced acute lung injury through suppression of
TLR4 signaling pathways. Exp Lung Res. 46:11–22. 2020.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ouyang W, Zhou H, Liu C, Wang S, Han Y,
Xia J and Xu F: 25-Hydroxycholesterol protects against acute lung
injury via targeting MD-2. J Cell Mol Med. 22:5494–5503.
2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Shirey KA, Lai W, Scott AJ, Lipsky M,
Mistry P, Pletneva LM, Karp CL, McAlees J, Gioannini TL, Weiss J,
et al: The TLR4 antagonist Eritoran protects mice from lethal
influenza infection. Nature. 497:498–502. 2013.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Cheng AM, Byrom MW, Shelton J and Ford LP:
Antisense inhibition of human miRNAs and indications for an
involvement of miRNA in cell growth and apoptosis. Nucleic Acids
Res. 33:1290–1297. 2005.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Liu CJ, Fu X, Xia M, Zhang Q, Gu Z and Guo
AY: MiRNASNP-v3: A comprehensive database for SNPs and
disease-related variations in miRNAs and miRNA targets. Nucleic
Acids Res. 49 (D1):D1276–D1281. 2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Zhou X, Li X, Ye Y, Zhao K, Zhuang Y, Li
Y, Wei Y and Wu M: MicroRNA-302b augments host defense to bacteria
by regulating inflammatory responses via feedback to TLR/IRAK4
circuits. Nat Commun. 5(3619)2014.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Wang B, Li X, Zhao G, Yan H, Dong P,
Watari H, Sims M, Li W, Pfeffer LM, Guo Y and Yue J: MiR-203
inhibits ovarian tumor metastasis by targeting BIRC5 and
attenuating the TGFβ pathway. J Exp Clin Cancer Res.
37(235)2018.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhu M, Li Y and Sun K: MicroRNA-182-5p
inhibits inflammation in LPS-treated RAW264.7 cells by mediating
the TLR4/NF-κB signaling pathway. Int J Clin Exp Pathol.
11:5725–5734. 2018.PubMed/NCBI
|
|
48
|
Goncalves Fernandes J, Morford LA,
Harrison PL, Kompotiati T, Huang H, Aukhil I, Wallet SM and
Macchion Shaddox L: Dysregulation of genes and microRNAs in
localized aggressive periodontitis. J Clin Periodontol.
47:1317–1325. 2020.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Braga TV, Evangelista FCG, Gomes LC,
Araujo SSDS, Carvalho MDG and Sabino AP: Evaluation of MiR-15a and
MiR-16-1 as prognostic biomarkers in chronic lymphocytic leukemia.
Biomed Pharmacother. 92:864–869. 2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Fennell D: MiR-16: Expanding the range of
molecular targets in mesothelioma. Lancet Oncol. 18:1296–1297.
2017.PubMed/NCBI View Article : Google Scholar
|
